Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

被引：0
|
作者：
Margarita-Ioanna Koufaki
Vasileios Fragoulakis
Xando Díaz-Villamarín
Kariofyllis Karamperis
Athanassios Vozikis
Jesse J. Swen
Cristina L. Dávila-Fajardo
Konstantinos Z. Vasileiou
George P. Patrinos
Christina Mitropoulou
机构：
[1] University of Patras School of Health Sciences,Laboratory of Pharmacogenomics and Individualized Therapy, Department of Pharmacy
[2] The Golden Helix Foundation,Laboratory of Health Economics and Management (LabHEM), Economics Department
[3] Instituto de Investigación Biosanitaria de Granada (ibs.Granada),Clinical Pharmacy Department
[4] University of Piraeus,Department of Genetics and Genomics, College of Medicine and Health Sciences
[5] Leiden University Medical Center,Zayed Center for Health Sciences
[6] Hospital Universitario Virgen de las Nieves,undefined
[7] Instituto de Investigación Biosanitaria (ibs.Granada),undefined
[8] United Arab Emirates University,undefined
[9] United Arab Emirates University,undefined
来源：
Human Genomics | / 17卷
关键词：
Clopidogrel; Economic evaluation; Cost-effectiveness; Pharmacogenomics-guided treatment; Spain; Acute coronary syndrome; PREPARE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 17 条
  • [1] Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
    Koufaki, Margarita-Ioanna
    Fragoulakis, Vasileios
    Diaz-Villamarin, Xando
    Karamperis, Kariofyllis
    Vozikis, Athanassios
    Swen, Jesse J.
    Davila-Fajardo, Cristina L.
    Vasileiou, Konstantinos Z.
    Patrinos, George P.
    Mitropoulou, Christina
    HUMAN GENOMICS, 2023, 17 (01)
  • [2] Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study
    Fragoulakis, Vasileios
    Koufaki, Margarita-Ioanna
    Joefield-Roka, Candace
    Sunder-Plassmann, Gere
    Mitropoulou, Christina
    PHARMACOGENOMICS JOURNAL, 2024, 24 (02):
  • [3] Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study
    Vasileios Fragoulakis
    Margarita-Ioanna Koufaki
    Candace Joefield-Roka
    Gere Sunder-Plassmann
    Christina Mitropoulou
    The Pharmacogenomics Journal, 2024, 24
  • [4] Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
    Fragoulakis, Vasileios
    Roncato, Rossana
    Bignucolo, Alessia
    Patrinos, George P.
    Toffoli, Giuseppe
    Cecchin, Erika
    Mitropoulou, Christina
    PHARMACOLOGICAL RESEARCH, 2023, 197
  • [5] Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment of Slovenian patients undergoing kidney transplantation in the U-PGx PREPARE study
    Fragoulakis, Vasileios
    Koufaki, Margarita-Ioanna
    Mlinsek, Gregor
    Blagus, Tanja
    Klen, Jasna
    Patrinos, George P.
    Dolzan, Vita
    Mitropoulou, Christina
    PHARMACOGENOMICS JOURNAL, 2025, 25 (1-2):
  • [6] IMPLEMENTING PRE-EMPTIVE PHARMACOGENOMIC TESTING FOR A PANEL OF PHARMACOGENES IN THE PREPARE STUDY (U-PGx CONSORTIUM): RESULTS FROM THE FIRST 1,000 PATIENTS.
    van der Wouden, C. H.
    Davila-Fajardo, C.
    Dolzan, V.
    Patrinos, G. P.
    Pirmohamed, M.
    Sunder-Plassmann, G.
    Toffoli, G.
    Swen, J. J.
    Guchelaar, H-J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S13 - S13
  • [7] GLYCOPROTEIN INHIBITOR USE IN ACUTE CORONARY SYNDROME PATIENTS IN 2007: RESULTS FROM THE ANTIPLATELET TREATMENT OBSERVATIONAL STUDY (APTOR)
    Zeymer, U.
    Leidreiter, K.
    Bakhai, A.
    Iniguez, Romo A.
    Ferrieres, J.
    VALUE IN HEALTH, 2008, 11 (06) : A419 - A419
  • [8] Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland
    Prami, T.
    Khanfir, H.
    Deleskog, A.
    Hasvold, P.
    Kyto, V.
    Reissell, E.
    Airaksinen, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 378 - 379
  • [9] HEALTH ECONOMIC EVALUATION OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY PATIENTS (ACS) BASED ON THE PLATO STUDY FROM A SPANISH HEALTH CARE PERSPECTIVE
    Delgado-Ortega, L.
    Lopez-Sendon, J. L.
    Heras Fortuny, M.
    Alvarez Sanz, C.
    Nikolic, E.
    Mellstrom, C.
    Wallentin, L.
    VALUE IN HEALTH, 2011, 14 (07) : A372 - A372
  • [10] Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial
    Orban, Martin
    Trenk, Dietmar
    Geisler, Tobias
    Rieber, Johannes
    Hadamitzky, Martin
    Gross, Lisa
    Orban, Mathias
    Kupka, Danny
    Baylacher, Monika
    Mueller, Susan
    Huber, Kurt
    Koltowski, Lukasz
    Huczek, Zenon
    Heyn, Jens
    Jacobshagen, Claudius
    Aradi, Daniel
    Massberg, Steffen
    Sibbing, Dirk
    Hein, Ralph
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (06) : 372 - 381
12